NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
TOP NEWS
Charles River
»28/07/2009 [Company watch]
Charles River Shanghai Achieves Accreditation Milestone

On the heels of its grand opening in October, the Charles River preclinical facility in Shanghai has been awarded Shanghai Laboratory Animal Commission (SLAC) Accreditation and full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).

 
On the heels of its grand opening in October, the Charles River preclinical facility in Shanghai has been awarded Shanghai Laboratory Animal Commission (SLAC) Accreditation and full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). These accreditations mark a significant milestone in the facility’s ability to help multinationals and local biopharmaceutical organizations accelerate their drug development programs. The SLAC accreditation process involved an audit and inspection of the facility as well as reviewing relevant documents, including SOPs, training and education programs and safety manuals. Charles River was commended for its excellent animal welfare policies and procedures, comprehensive emergency plan, training programs and security by the SLAC. This accreditation will enable Charles River’s China facility to provide a wide range of services that are compliant with leading regulatory agencies. The AAALAC report, which followed a site evaluation in March 2009, was particularly complimentary of the strong commitment to the animal care and use program, the state-of-the-art facility and equipment and the dedicated and highly capable staff. Preclinical Services Shanghai was also commended for its excellent documentation practices and record-keeping. Charles River is committed to the humane care of the research animals produced and used in all of our activities. This commitment extends not just to mere compliance with applicable local laws and regulations, but to going beyond compliance to ensure that Charles River continues as a worldwide leader in the humane care of laboratory animals. As animal caregivers and researchers, we are responsible to our clients and the public for the health and well-being of the animals in our care.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.